Cargando…

Pharmacological Neuroenhancement: Current Aspects of Categorization, Epidemiology, Pharmacology, Drug Development, Ethics, and Future Perspectives

Recent pharmacoepidemiologic studies suggest that pharmacological neuroenhancement (pNE) and mood enhancement are globally expanding phenomena with distinctly different regional characteristics. Sociocultural and regulatory aspects, as well as health policies, play a central role in addition to medi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Daubner, Johanna, Arshaad, Muhammad Imran, Henseler, Christina, Hescheler, Jürgen, Ehninger, Dan, Broich, Karl, Rawashdeh, Oliver, Papazoglou, Anna, Weiergräber, Marco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2021
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7817276/ https://www.ncbi.nlm.nih.gov/pubmed/33519929 http://dx.doi.org/10.1155/2021/8823383

Ejemplares similares

Ca(v)3 T-Type Voltage-Gated Ca(2+) Channels and the Amyloidogenic Environment: Pathophysiology and Implications on Pharmacotherapy and Pharmacovigilance
por: Papazoglou, Anna, et al.
Publicado: (2022)

Spontaneous long-term and urethane induced hippocampal EEG power, activity and temperature data from mice lacking the Ca(v)3.2 voltage-gated Ca(2+) channel
por: Papazoglou, Anna, et al.
Publicado: (2021)

Enhanced hippocampal type II theta activity AND altered theta architecture in mice lacking the Ca(v)3.2 T-type voltage-gated calcium channel
por: Arshaad, Muhammad Imran, et al.
Publicado: (2021)

The Janus-like Association between Proton Pump Inhibitors and Dementia
por: Papazoglou, Anna, et al.
Publicado: (2021)

Breeding of Ca(v)2.3 deficient mice reveals Mendelian inheritance in contrast to complex inheritance in Ca(v)3.2 null mutant breeding
por: Papazoglou, Anna, et al.
Publicado: (2021)

Whole genome transcriptome data from the WT cortex and hippocampus of female and male control and APP/PS1 Alzheimer's disease mice
por: Papazoglou, Anna, et al.
Publicado: (2023)

Gender specific click and tone burst evoked ABR datasets from mice lacking the Ca(v)3.2 T-type voltage-gated calcium channel
por: Lundt, Andreas, et al.
Publicado: (2019)

Gender specific click and tone burst evoked ABR datasets from mice lacking the Ca(v)2.3 R-type voltage-gated calcium channel
por: Lundt, Andreas, et al.
Publicado: (2018)

Gender specific hippocampal whole genome transcriptome data from mice lacking the Ca(v)2.3 R-type or Ca(v)3.2 T-type voltage-gated calcium channel
por: Papazoglou, Anna, et al.
Publicado: (2017)

EEG Radiotelemetry in Small Laboratory Rodents: A Powerful State-of-the Art Approach in Neuropsychiatric, Neurodegenerative, and Epilepsy Research
por: Lundt, Andreas, et al.
Publicado: (2016)

Altered Theta Oscillations and Aberrant Cortical Excitatory Activity in the 5XFAD Model of Alzheimer's Disease
por: Siwek, Magdalena Elisabeth, et al.
Publicado: (2015)

Review: Ca(v)2.3 R-type Voltage-Gated Ca(2+) Channels - Functional Implications in Convulsive and Non-convulsive Seizure Activity
por: Wormuth, Carola, et al.
Publicado: (2016)

How Realistic Are the Scientific Assumptions of the Neuroenhancement Debate? Assessing the Pharmacological Optimism and Neuroenhancement Prevalence Hypotheses
por: Schleim, Stephan, et al.
Publicado: (2018)

Sensitivity of Quantitative Signal Detection in Regards to Pharmacological Neuroenhancement
por: Gahr, Maximilian, et al.
Publicado: (2017)

Motor Cortex Theta and Gamma Architecture in Young Adult APPswePS1dE9 Alzheimer Mice
por: Papazoglou, Anna, et al.
Publicado: (2017)

Gender-Specific Hippocampal Dysrhythmia and Aberrant Hippocampal and Cortical Excitability in the APPswePS1dE9 Model of Alzheimer's Disease
por: Papazoglou, Anna, et al.
Publicado: (2016)

The relevance of pharmacological neuroenhancement for stress and resilience—A multistudy report
por: Darwig, Julia, et al.
Publicado: (2022)

The is and ought of the Ethics of Neuroenhancement: Mind the Gap
por: Forlini, Cynthia, et al.
Publicado: (2016)

Pharmacological Neuroenhancement in the Field of Economics—Poll Results from an Online Survey
por: Dietz, Pavel, et al.
Publicado: (2016)

Bottom Up Ethics - Neuroenhancement in Education and Employment
por: Bard, Imre, et al.
Publicado: (2018)

On pharmacological neuroenhancement as part of the new neurorights' pioneering legislation in Chile: a perspective
por: Cornejo-Plaza, María Isabel, et al.
Publicado: (2023)

Focus on neuroenhancement: a systematic review and its ethical implications
por: Massa, L., et al.
Publicado: (2022)

Pharmacological Neuroenhancement: teachers’ knowledge and attitudes–Results from a survey study among teachers in Germany
por: Franke, Andreas G., et al.
Publicado: (2016)

Pharmacological neuroenhancement and the ability to recover from stress – a representative cross-sectional survey among the German population
por: Bagusat, Christiana, et al.
Publicado: (2018)

Potential risk groups and psychological, psychosocial, and health behavioral predictors of pharmacological neuroenhancement among university students in Germany
por: Heller, Sebastian, et al.
Publicado: (2022)

Biological markers for early detection and pharmacological treatment of Alzheimer's disease
por: Hampel, Harald, et al.
Publicado: (2009)

Prevalence Estimates for Pharmacological Neuroenhancement in Austrian University Students: Its Relation to Health-Related Risk Attitude and the Framing Effect of Caffeine Tablets
por: Dietz, Pavel, et al.
Publicado: (2018)

Natural Selection, Childrearing, and the Ethics of Marriage (and Divorce): Building a Case for the Neuroenhancement of Human Relationships
por: Earp, Brian D., et al.
Publicado: (2012)

Neuroenhancements in the Military: A Mixed-Method Pilot Study on Attitudes of Staff Officers to Ethics and Rules
por: Sattler, Sebastian, et al.
Publicado: (2022)

Limited Effects of an eIF2α (S51A) Allele on Neurological Impairments in the 5xFAD Mouse Model of Alzheimer's Disease
por: Paesler, Katharina, et al.
Publicado: (2015)

Physiological and pharmacological aspects of the vas deferens—an update
por: Koslov, David S., et al.
Publicado: (2013)

Neuroenhancement of Exposure Therapy in Anxiety Disorders
por: Hofmann, Stefan G., et al.
Publicado: (2015)

Neuroenhancement and the strength model of self-control
por: Englert, Chris, et al.
Publicado: (2015)

Can self-validating neuroenhancement be autonomous?
por: Varelius, Jukka
Publicado: (2019)

Just “Like Coffee” or Neuroenhancement by Stimulants?
por: Franke, Andreas G., et al.
Publicado: (2021)

Neuroenhancement: State of the Art and Future Perspectives
por: Marazziti, Donatella, et al.
Publicado: (2021)

Neuroenhancement of surgeons during robotic suturing
por: Patel, Ronak, et al.
Publicado: (2021)

Non-invasive brain stimulation and neuroenhancement
por: Antal, Andrea, et al.
Publicado: (2022)

Chemical and Pharmacological Aspects of Capsaicin
por: Reyes-Escogido, Maria de Lourdes, et al.
Publicado: (2011)

The Prevalence of Pharmacological Neuroenhancement Among University Students Before and During the COVID-19-Pandemic: Results of Three Consecutive Cross-Sectional Survey Studies in Germany
por: Dietz, Pavel, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_be2k41osda53807n20msjvfli7